Clinical TrialsSearch results
Number of results: 216
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- [M25-145] A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Upadacitinib in Combination with Topical Corticosteroids in Children from 2 to Less than 12 Years of Age in Japan with Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Fujimura Kimino
- 2024-12-10
Recruiting
- A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
- Hidradenitis Suppurativa
- Yamazaki Hayato
- 2023-06-27
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01
Recruiting
- A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo
- NonSegmental Vitiligo
- Ono Shintaro
- 2024-06-14
Recruiting
- A study to evaluate efficacy and safety of SAR441566 in adults with plaque psoriasis
- Psoriasis
- Tanaka Tomoyuki
- 2024-01-09
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab in participants aged 18 years and older with moderate-to-severe atopic dermatitis on background topical corticosteroids
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-01-13
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in adult participants with severe alopecia areata
- Alopecia areata
- Tanaka Tomoyuki
- 2024-07-07
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in participants aged 18 years and older with moderate-to-severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-01-13
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab on background topical corticosteroids therapy in participants aged 12 years and older with moderate-to-severe AD who have had an inadequate response to prior biologic therapy or an oral JAK inhibitor
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-05-08
Recruiting
- A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
- Ulcerative colitis or Crohn's Disease
- Kashiyama Akinori
- 2023-04-11